hotspot -WSS

hotspot

author：explore 2025-10-02 10:45:28 - browse：4526

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Should insurance cover cosmetic surgery?

WSS

Asahi Kasei to buy Calliditas, picking up kidney disease drug

In search for therapies for solid tumors, companies turn to claudin

Why getting cancer drugs just got harder for rural patients

New research sheds light on how often breast cancer is overdiagnosed

Protect nursing home residents from future pandemics

FogPharma raises $145 million in rare Series E round

leisure time

hotspot

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Beyond aggravation: Constipation is an American epidemic

Heart attack and stroke risk calculators need revising

Congress gives doctors Medicare pay bump

BioMarin wins approval for gene therapy to treat hemophilia A

Decentralized clinical trials need collaboration to achieve wider use

Activists slam private health insurers over coverage restrictions

Should insurance cover cosmetic surgery?

Trump demands the U.S. pay no more for drugs than other countries … again

Should insurance cover cosmetic surgery?

Wikipedia

The Bio Revolution is changing business and society

Kenai launches with $82 million for Parkinson’s stem cell therapy

Change Healthcare cyberattack outage could last weeks

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Biotech companies concerned about China biosecurity crackdown

leisure time

entertainment

knowledge

hotspot